The Infectious Disease Testing Market in 2023 is US$ 25.37 billion, and is expected to reach US$ 39.59 billion by 2031 at a CAGR of 5.72%.
FutureWise Research published a report that analyzes Infectious Disease Testing Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based...
The global point of care infectious disease testing market size is expected to reach USD 15.76 billion by 2030, registering a CAGR of 4.3%, according to a new report by Grand View Research, Inc. The emerging trend of patient-centric services coupled with escalating incidence rates of complicated infectious disorders is expected to upsurge the demand for portable and accurate detection devices,...
The Digital PCR (dPCR) Market is on a rapid growth trajectory, with its size valued at USD 515 million in 2023. Projections indicate that this market is expected to soar to USD 3.32 billion by 2032, reflecting a remarkable compound annual growth rate (CAGR) of 23% over the forecast period from 2024 to 2032. The increasing demand for precision medicine and advancements in genetic research are...
The Tuberculosis Vaccine Market was characterized by intense competition among several pharmaceutical companies and research institutions. The leading players in the market included Sanofi Pasteur, GlaxoSmithKline (GSK), Serum Institute of India, and IDT Biologika GmbH, among others. The competition was primarily driven by the urgent global need to combat tuberculosis, which remained a...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian